ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
GeoVax Labs Inc

GeoVax Labs Inc (GOVX)

2.52
0.33
(15.07%)
Closed December 06 3:00PM
2.52
0.00
(0.00%)
After Hours: 6:59PM

Empower your portfolio: Real-time discussions and actionable trading ideas.

Key stats and details

Current Price
2.52
Bid
2.47
Ask
2.52
Volume
1,042,052
2.23 Day's Range 2.5296
1.0901 52 Week Range 11.18
Market Cap
Previous Close
2.19
Open
2.23
Last Trade
90
@
2.47
Last Trade Time
Financial Volume
US$ 2,496,016
VWAP
2.3953
Average Volume (3m)
1,728,249
Shares Outstanding
9,436,069
Dividend Yield
-
PE Ratio
-0.92
Earnings Per Share (EPS)
-2.75
Revenue
-
Net Profit
-25.97M

About GeoVax Labs Inc

Geovax Labs Inc is us-based clinical-stage biotechnology company. Geovax Labs Inc is us-based clinical-stage biotechnology company.

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Website
Headquarters
Wilmington, Delaware, USA
Founded
-
GeoVax Labs Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker GOVX. The last closing price for GeoVax Labs was US$2.19. Over the last year, GeoVax Labs shares have traded in a share price range of US$ 1.0901 to US$ 11.18.

GeoVax Labs currently has 9,436,069 shares outstanding. The market capitalization of GeoVax Labs is US$20.66 million. GeoVax Labs has a price to earnings ratio (PE ratio) of -0.92.

GOVX Latest News

GeoVax to Present at the Noble Capital Markets Twentieth Annual Emerging Growth Equity Conference

ATLANTA, Nov. 26, 2024 (GLOBE NEWSWIRE) -- GeoVax Labs, Inc. (Nasdaq: GOVX), a biotechnology company specializing in developing human vaccines and cancer immunotherapies, today announced that...

GeoVax Announces Positive Interim Data Review for Phase 2 Clinical Trial of COVID-19 Vaccine Booster in Patients with Chronic Lymphocytic Leukemia

GEO-CM04S1 Improved Immune Response vs mRNA Vaccine ATLANTA, Nov. 19, 2024 (GLOBE NEWSWIRE) -- GeoVax Labs, Inc. (Nasdaq: GOVX), a biotechnology company developing immunotherapies and...

GeoVax Reports Third Quarter 2024 Financial Results and Provides Business Update

Progress in GEO-CM04S1 BARDA/Project NextGen Phase 2b trial; multiple data readouts of existing COVID-19 vaccine Phase 2 trials expected during fourth quarter 2024 Gedeptin® on track to advance...

GeoVax to Report Third Quarter 2024 Financial Results and Provide Corporate Update on November 12, 2024

GeoVax to Host Conference Call at 4:30 PM ET ATLANTA, Nov. 05, 2024 (GLOBE NEWSWIRE) -- GeoVax Labs, Inc. (Nasdaq: GOVX), a biotechnology company developing immunotherapies and vaccines against...

GeoVax to Participate in the 3rd Annual ROTH Healthcare Opportunities Conference

ATLANTA, Ga., Oct. 02, 2024 (GLOBE NEWSWIRE) -- GeoVax Labs, Inc. (Nasdaq: GOVX), a biotechnology company specializing in developing human vaccines and cancer immunotherapies, today announced...

GeoVax to Participate in Upcoming Investor Conferences in September

ATLANTA, GA, Sept. 03, 2024 (GLOBE NEWSWIRE) -- GeoVax Labs, Inc. (Nasdaq: GOVX), a biotechnology company developing immunotherapies and vaccines against cancers and infectious diseases, today...

GeoVax to Raise Approximately $5.0 Million of Gross Proceeds in Offering Priced At-the-Market

ATLANTA, GA, Aug. 28, 2024 (GLOBE NEWSWIRE) -- GeoVax Labs, Inc. (Nasdaq: GOVX), a clinical-stage biotechnology company developing immunotherapies and vaccines against cancer and infectious...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-0.19-7.01107011072.712.772.175791252.39722694CS
40.5729.23076923081.953.881.8836280983.06952329CS
12-0.58-18.70967741943.13.881.7517282492.83710093CS
260.6534.75935828881.8711.181.090142715194.61072314CS
52-3.33-56.92307692315.8511.181.090122208914.59346332CS
156-52.08-95.384615384654.664.51.0901370267125.50083828CS
260-42.48-94.445130.651.0901308595532.49304747CS

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
UPCUniverse Pharmaceuticals Inc
US$ 3.38
(221.90%)
93.72M
LIFWMSP Recovery Inc
US$ 3.2461
(104.16%)
29.08M
GXAIGaxos ai Inc
US$ 2.5801
(81.70%)
146.21M
SBETSharpLink Gaming Inc
US$ 0.9116
(73.97%)
27.09M
HCTIHealthcare Triangle Inc
US$ 1.165
(68.38%)
4.34M
ORISOriental Rise Holdings Ltd
US$ 3.6833
(-93.42%)
27.58M
LICNLichen China Limited
US$ 0.4895
(-76.91%)
186.02M
MYNAMynaric AG
US$ 0.499246
(-64.59%)
3.62M
CEROCERo Therapeutics Holdings Inc
US$ 0.1146
(-40.16%)
38.21M
BTCTBTC Digital Ltd
US$ 10.50
(-32.95%)
3.31M
SMXSMX Security Matters Public Company
US$ 0.4879
(64.06%)
448.58M
SOUNSoundHound AI Inc
US$ 15.01
(12.60%)
218.94M
NVDANVIDIA Corporation
US$ 142.44
(-1.81%)
187.57M
LICNLichen China Limited
US$ 0.4895
(-76.91%)
186.02M
SVMHSRIVARU Holding Ltd
US$ 0.0293
(-16.29%)
162.46M

GOVX Discussion

View Posts
silkman silkman 3 weeks ago
Bullish?
👍️0
glenn1919 glenn1919 3 weeks ago
GOVX....................................https://stockcharts.com/h-sc/ui?s=GOVX&p=W&b=5&g=0&id=p86431144783
👍️0
Snoop_dog Snoop_dog 3 weeks ago
Anyone know if they working on H5N1?
👍️0
PonkenPlonken PonkenPlonken 3 weeks ago
go go
👍️0
glenn1919 glenn1919 4 weeks ago
GOVX...................................https://stockcharts.com/h-sc/ui?s=GOVX&p=W&b=5&g=0&id=p86431144783
👍️0
tw0122 tw0122 4 weeks ago
GOVX $3.57 + 80% kept a few $1.70s. 
👍️0
tw0122 tw0122 4 weeks ago
GOVX $2.80s + 50%🔥🔥🔥🔥📞🚀🚀🚀🚀
👍 1 🚀 1
tw0122 tw0122 4 weeks ago
Rockets fired $2.70s + 40% sold most 
👍 1 🚀 1
glenn1919 glenn1919 4 weeks ago
govx...............................https://stockcharts.com/h-sc/ui?s=GOVX&p=W&b=5&g=0&id=p86431144783
👍 1 🚀 1
tw0122 tw0122 4 weeks ago
GOVX $1:96 + 1% earnings 11-12
👍️0
tw0122 tw0122 4 weeks ago
Have plenty of $1.70s financial results Nov 12 afterhours 
👍️0
tw0122 tw0122 1 month ago
Some climbing again 2.26
👍️0
PonkenPlonken PonkenPlonken 2 months ago
crawling out of its hole
keep on watch
👍️0
tw0122 tw0122 2 months ago
GOVX 2.20s offshore hedgies hit some.. The government will also provide around $343M for a clinical research organization to conduct the clinical trial. Under the agreement, BARDA will award GeoVax up to $45M for the manufacturing of clinical materials and support for the Phase 2b study
👍️0
Trompete Trompete 2 months ago
GARBAGE, TRASH, WORTHLESS
👍️0
tw0122 tw0122 2 months ago
$2.07 Offshore hedgies could hit here again but could be a month or two out still
👍️0
tw0122 tw0122 2 months ago
Ok $1.90- $2s flipper
👍️0
tw0122 tw0122 2 months ago
Confirm reversal on candle on 3rd day
👍️0
tw0122 tw0122 3 months ago
Ok ok we see you ..but going to hold $3s this time or another fake out. Support been at $2.60s past few weeks. Looking better
👍️0
tw0122 tw0122 3 months ago
Mpox has spread to at least 14 African countries, including Morocco, which has confirmed its first case in the current outbreak. (Source: BBC Africa)
The Democratic Republic of Congo (DRC) is the epicenter of the outbreak, with over 20,000 cases reported and more than 500 deaths. (Source: WHO)
Neighboring countries, such as Burundi, Kenya, Rwanda, and Uganda, have also reported cases. (Source: WHO)
Vaccination Efforts

The World Health Organization (WHO) recommends use of MVA-BN or LC16 vaccines, or the ACAM2000 vaccine when others are not available. (Source: WHO)
Only people at risk of exposure to mpox should be considered for vaccination, according to WHO. (Source: WHO)
Transmission and Prevention

Mpox is primarily spread through close person-to-person contact with someone who is infected, including through sex. (Source: Nature)
Cleaning and disinfecting surfaces or objects and washing hands after touching contaminated surfaces or objects can help prevent transmission. (Source: WHO)
Avoiding unprotected contact with wild animals, especially those that are sick or dead, and cooking food thoroughly can reduce the risk of getting mpox from animals. (Source: WHO)
Public Health Emergency

The WHO declared the mpox outbreak a Public Health Emergency of International Concern (PHEIC) on August 19, 2024, citing the rapid spread of a new, more transmissible strain of the virus. (Source: WHO)
Research and Development

Scientists are racing to answer questions about the outbreak, including whether vaccines will curb the spread and how the virus is transmitted. (Source: Nature)
👍️ 1
tw0122 tw0122 3 months ago
Looking good bottom about in for hedgies
👍️0
tw0122 tw0122 3 months ago
Watch for 2.52 - .2.92 too hold for flip. 2.08- 2.20 next zone underneath if doesn’t
👍️0
tw0122 tw0122 3 months ago
Hedgies determine new downtrend. New entry as we see $2.80s for another flip
👍️0
tw0122 tw0122 3 months ago
Ok hedgies confirming new upward trend perhaps give it a few hours still
👍️0
tw0122 tw0122 3 months ago
Flip the $3.06 at 3.30s and wait for hedgies to determine direction
👍️0
tw0122 tw0122 3 months ago
Tummies yummy $3.06 bought and then if happens to test next level down add again.
Hedgies want to take it as low as possible before the next big run into Covid vaccine season. Luv you Gary Gensler
👍️0
tw0122 tw0122 3 months ago
Good sign 3.06 hedgies covering shorts now volume picking up 600,000. Almost time to add some more goodies
👍️0
tw0122 tw0122 3 months ago
3.19 zone being tested if holds a few days start adding some again
👍️0
tw0122 tw0122 3 months ago
price of $5.125 per share for expected gross proceeds of $5 million.

4:39 AM EDT, 08/29/2024 (MT Newswires) -- GeoVax Labs (GOVX) said late Wednesday it has agreed to sell 975,610 common shares in a registered direct offering to an institutional investor at a price of $5.125 per share for expected gross proceeds of $5 million.

The company will also issue warrants to purchase up to 975,610 common shares to the investor in a concurrent private placement, it said. The warrants will be exercisable at a price of $5 per share.

Net proceeds will be used for working capital and general corporate purposes, the company said.

The offering is expected to close around Friday, sub
👍️0
tw0122 tw0122 3 months ago
Test 3.19- 3.55 zone wait to confirm before pulling trigger $2.52- 2.92 is the other zone. The hedgies that have most of the shares will determine that as they move this one as they please
👍️0
tw0122 tw0122 3 months ago
Covid flue season blooming still holding a few here but inclined to add some more ..

GeoVax Labs, Inc. is a clinical-stage biotechnology company developing novel vaccines for many of the world’s most threatening infectious diseases and therapies for solid tumor cancers. The company’s lead clinical program is GEO-CM04S1, a next-generation COVID-19 vaccine for which GeoVax was recently awarded a BARDA-funded contract to sponsor a 10,000-participant Phase 2b clinical trial to evaluate the efficacy of GEO-CM04S1 versus an approved COVID-19 vaccine. In addition, GEO-CM04S1 is currently in three Phase 2 clinical trials, being evaluated as (1) a primary vaccine for immunocompromised patients such as those suffering from hematologic cancers and other patient populations for whom the current authorized COVID-19 vaccines are insufficient, (2) a booster vaccine in patients with chronic lymphocytic leukemia (CLL) and (3) a more robust, durable COVID-19 booster among healthy patients who previously received the mRNA vaccines. In oncology the lead clinical program is evaluating a novel oncolytic solid tumor gene-directed therapy, Gedeptin®, in a multicenter Phase 1/2 clinical trial for advanced head and neck cancers. GeoVax has a strong IP portfolio in support of its technologies and product candidates, holding worldwide rights for its technologies and products. The Company has a leadership team who have driven significant value creation across multiple life science companies over the past several decades. For more information about the current status of our clinical trials and other updates, visit our website: www.geovax.com.
👍️0
Gman3343 Gman3343 3 months ago
Going under 2.00 then time to buy.
👍️0
Monksdream Monksdream 3 months ago
GOVX under $5
👍️0
81vette 81vette 3 months ago
Warrents jumped up 100%
👍️0
Biggiee Biggiee 3 months ago
The Fauch knows how to party!
👍️0
Gman3343 Gman3343 3 months ago
Maybe the evil bastard will drop dead .
👍️0
tw0122 tw0122 3 months ago
Buy 6.30s sell $7.30s was todays lesson dip time coming again.. Dr. Fauci Somehow Contracts Ultra-Rare West Nile Virus On Heels Of COVID-19 Infection
👍️0
Gman3343 Gman3343 3 months ago
Good, keep giving that evil idiot all my vaccines and boosters.
He should double up
👍️0
tw0122 tw0122 3 months ago
Catch the dips play next.. Dr. Fauci has COVID again for the third time and has been vaccinated and boosted six times
👍️0
glenn1919 glenn1919 3 months ago
GOVX...............................https://stockcharts.com/h-sc/ui?s=GOVX&p=W&b=5&g=0&id=p86431144783
👍️0
tw0122 tw0122 3 months ago
sale of 1,700,000 shares of the Company’s common stock (or common stock equivalents) at a price of $5.00 per share in a registered direct offering priced above-the-market under Nasdaq rules.
In addition, in a concurrent private placement, the Company will issue to the investor warrants to purchase up to 1,700,000 shares of common stock. The warrants have an exercise price of $5.00 per share, will be exercisable immediately following the date of issuance and will have a term of five years from the date of issuance.
👍️0
ipo_dude ipo_dude 4 months ago
I wish ..
👍️0
rouge Vaughn rouge Vaughn 4 months ago
15 to 20 let's goooo
👍️0
tw0122 tw0122 4 months ago
Next stop $15 then $20…By Amanda Alvarado
Published: Aug. 21, 2024 at 8:02 AM EDT
(Gray News) - COVID-19 cases are rising and KP.3.1.1 is the predominant variant in the United States, according to the Centers for Disease Control and Prevention.

The variant accounted for between 31% and 43% of the cases in the two-week period ending on Aug. 17.

KP.3.1.1 is currently the only major variant increasing in proportion nationally, according to the CDC.

Emergency room visits diagnosed as COVID-19 started increasing in May in the West and are now the highest in the South and Southeast. The wastewater viral activity level for COVID-19 has been rising since mid-May and is currently very high across most parts of the country, according to the CDC.
👍️0
tw0122 tw0122 4 months ago
- Kamala Harris issues vaccine mandate for campaign workers..Good news for vaccine makers pump em up.
👍️0
tw0122 tw0122 4 months ago
Still have $1.80 shares left from a couple weeks back holding for the Gold longer term rest been cashed out
👍️ 1
glenn1919 glenn1919 4 months ago
GOVX....................................https://stockcharts.com/h-sc/ui?s=GOVX&p=W&b=5&g=0&id=p86431144783
👍️0
Backstabbed Backstabbed 4 months ago
Damn… nice play guys. Missed this one. I bought my first stock today in months!

Been terrible year
👍️0
81vette 81vette 4 months ago
Huge winner today,warrents was even better because of big spread, easy 15-19% wins
👍️0
gail gail 4 months ago
and back out before the dump, but it tried.
👍️0

Your Recent History

Delayed Upgrade Clock